spacer
home > pmps > autumn 2018 > cold chain compliance
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Cold Chain Compliance

Maintaining end-to-end cold chain integrity is critical, with packaging vendors also utilising advanced temperature monitoring systems to help combat current cool chain challenges. Therefore, deploying high-performing, temperaturecontrolled packaging (TCP) solutions is vital to avoid temperature excursions within the pharmaceutical logistics cool chain and to help ensure the safe and secure transportation of health-giving and life-saving pharmaceutical products.

The market for transporting temperaturesensitive materials for healthcare, such as pharmaceuticals, blood, tissue, and organs, is a subsegment, currently valued at approximately US $2 billion and expected to grow to approximately US $5 billion by 2026.

With pharma companies developing ever-more complex and temperaturesensitive drugs, demand is growing to provide improved packaging performance and efficiency within cool chain logistics. Ensuring a secure, compliant cool chain from deployment of shipments to last mile delivery is also imperative.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Adam Tetz is the Director of Worldwide Marketing at Pelican BioThermal and has more than 20 years of marketing experience. He is responsible for worldwide branding, product launch, and communications strategy. Prior to Pelican BioThermal, Adam held positions in product management, marketing communications, and account management across a variety of industries, including medical software, financial software, and professional services. He holds an MBA in marketing from the University of St Thomas, US, and a BA in advertising from the University of Minnesota, US.
spacer
Adam Tetz
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Appointment of Lisa Spence as Director of Clinical Supply Chain International Region

Philadelphia, PA – March 12, 2019. Leading biopharmaceutical services provider PCI Clinical Services (PCI) is pleased to announce the appointment of Lisa Spence as Director of Clinical Supply Chain – International Region.
More info >>

White Papers

Maximize the ROI of Your Post-Approval Research

Bioclinica

Expenditures in post-approval (Phase IV) research are going up across the pharmaceutical, biotech and medical device industries. Given the resources you’ve committed to post-approval research, you may be wondering if you’re getting the greatest possible return on your investment. Discover how to harness the power of post-approval research to increase data collection, reduce resource burn, save money, and maximize your ROI!
More info >>

 
Industry Events

ASGCT 22nd Annual Meeting

29 April - 2 May 2019, Washington Hilton, Washington, D.C

The 2019 ASGCT Annual Meeting is expected to be the largest in Society history, eclipsing the mark set by the 2018 meeting just last year. Join more than 3,500 researchers, clinicians, advocates, and industry leaders in discovering the latest science and technology surrounding gene and cell therapy.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement